Health
US to widen inquiry into AstraZeneca COVID vaccine destined for Australia – Sydney Morning Herald
The US regulator has broadened its investigation of a serious illness in AstraZeneca’s COVID-19 vaccine study, a development closely watched by local regulators…
AstraZeneca has confirmed it is still awaiting the green light from US regulators to resume its US trials. The pharma giant’s Australian office wouldn’t comment further on how any delays would affect the timeline for when Australians receive the vaccine if successful.
Meanwhile, there was better news for the vaccine in Europe overnight, with reports the European Medicines Agency is expected to announce a “rolling review” of the Oxford/AstraZeneca candidate this week.
This would mean the Europe…
-
General11 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News20 hours agoChild, 15, arrested over death of another child, 8, after shocking e-bike crash in Queensland
-
Noosa News18 hours agoDeath of German shepherd Arnie prompts Brisbane community action to protect pets caught up in crime
-
General13 hours agoPerth man charged after investigation into organised crime and tobacco store attacks